Visionaire™ Versus Standard Instrumentation Safety and Efficacy in Total Knee Arthroplasty (TKA)
A Multicenter, Randomized, Clinical Outcome of VISIONAIRE™ Patient Matched Technology vs. Standard Surgical Instrumentation in Total Knee Arthroplasty
1 other identifier
interventional
134
2 countries
7
Brief Summary
The objective of this study is to assess outcomes following TKA, utilizing two surgical techniques. Patients will be randomized to one of two arms: TKA with standard instrumentation and TKA with VISIONAIRE™ patient-matched cutting blocks. Data will be collected at preoperative, operative/discharge, 3 months, 1 year and 2 years after TKA. The secondary objective of this study is to compare the safety, quality of life, and economic outcomes of TKA when these two techniques are utilized. This study does not involve treatment or investigational products, as all components are FDA cleared and are commercially available.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2012
Typical duration for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2010
CompletedFirst Posted
Study publicly available on registry
March 10, 2010
CompletedStudy Start
First participant enrolled
June 21, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedResults Posted
Study results publicly available
April 3, 2020
CompletedApril 3, 2020
March 1, 2020
1.8 years
February 19, 2010
February 14, 2020
March 20, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Knee Society Clinical (KSS) Score at 2 Years Following Surgery - Total Score
The KSS was used to rate both the prosthesis function and the patient's functional abilities after TKA. The KSS Total Score (0-100 points) included a combined evaluation of joint motion (0-25 points), instability (0-25 points), alignment (0-25 points), and symptoms (0-25 points). A higher score indicated a better outcome for subjects.
2 years postoperatively
Knee Society Clinical (KSS) Score at 2 Years Following Surgery - Clinical Evaluation Questionnaire
The KSS was used to rate both the prosthesis function and the patient's functional abilities after TKA. The KSS clinical evaluation included a questionnaire completed by the investigators to assess for pain, stability, flexion contracture, extension lag, and alignment and evaluated based on number of subjects experiencing any of these issues at the 2-year postoperative visit.
2 years postoperatively
Secondary Outcomes (11)
Evaluation of Mechanical Alignment Assessed as Either Neutral or Varus/Valgus 3 Months Postoperatively Using a Full Leg X-ray
3 months postoperative
Knee Injury and Osteoarthritis Outcome Score (KOOS) Preoperatively and Postoperatively
Baseline (preoperative), 3 months, 1 year, and 2 years postoperatively
Serial Radiographic Evaluations to Assess Evidence of Loosening (Radiolucencies) by Measuring Lucent Zones at 1 Year Postoperatively
1 year postoperatively
Radiographic Outcomes to Assess Evidence of Loosening at 1 Year Postoperatively
1 year postoperatively
Serial Radiographic Evaluations to Assess Evidence of Loosening at 2 Years Postoperatively
2 years postoperatively
- +6 more secondary outcomes
Study Arms (2)
VISIONAIRE Instrumentation
OTHERTKA with VISIONAIRE instrumentation
Standard Instrumentation
OTHERTKA with standard instrumentation
Interventions
TKA will be performed with VISIONAIRE instrumentation, depending on randomization assignment.
TKA will be performed with standard instrumentation, depending on randomization assignment.
Eligibility Criteria
You may qualify if:
- Patient diagnosed with degenerative arthritis of the knee requiring a unilateral primary TKA.
- Patient is of legal age to consent and is skeletally mature.
- Patient is willing to sign and date an ethics-approved consent form.
- Patient is willing to be available for two-year follow-up postoperatively
You may not qualify if:
- Patient is known to have poor bone stock making a TKA unjustifiable.
- Patient is immuno-suppressed.
- Patient has physical, emotional or neurological conditions that would compromise the patient's compliance with postoperative rehabilitation and follow-up.
- Patient is pregnant or may become pregnant during the course of the study.
- Patient has a history of prior ipsilateral major knee surgery (e.g. arthroplasty, high tibial osteotomy, or tibial plateau fracture). Minor prior procedures such as ACL repair, meniscectomy, or arthroscopy are not excluded.
- Patient has active, localized or systemic infection.
- Patient is severely overweight (BMI \>40).
- Patient is a prisoner.
- Patient has had a total joint arthroplasty of the contralateral limb in the last 12 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Orthopaedic Surgery Specialist, Ltd.
Park Ridge, Illinois, 60068, United States
Southern Illinois University School of Medicine
Springfield, Illinois, 62794-9679, United States
Town & Country Orthopedics
St Louis, Missouri, 63131, United States
University of Nebraska Medical Center
Omaha, Nebraska, 68198-1080, United States
Wake Forest University School of Medicine
Winston-Salem, North Carolina, 27157-1070, United States
Slocum Research & Education Foundation
Eugene, Oregon, 97401, United States
Malabar Orthopaedic Clinic
Windsor, Victoria, 3181, Australia
Limitations and Caveats
The major limitation for this study was not reaching the target number of participants needed to achieve target power and statistical analyses leading to uninterpretable data.
Results Point of Contact
- Title
- Stuart Pratt
- Organization
- Smith & Nephew, Inc.
Study Officials
- STUDY DIRECTOR
Beate Hanson, MD, PhD
Smith & Nephew, Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- GT60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2010
First Posted
March 10, 2010
Study Start
June 21, 2012
Primary Completion
April 15, 2014
Study Completion
September 1, 2015
Last Updated
April 3, 2020
Results First Posted
April 3, 2020
Record last verified: 2020-03